cuproptosis

In patients with GC, the cuproptosis- and cisplatin resistance-related signature could help predict prognosis, biological traits, immunotherapy effects, and cisplatin sensitivity.

对于胃癌（Gastric Cancer, GC）患者，与铜死亡（cuproptosis）及顺铂（cisplatin）耐药相关的特征基因集（signature）可辅助预测患者的预后、生物学特性、免疫治疗疗效以及顺铂敏感性。